| OXCARBAZEPINE-D4 |
奥卡西平-D4 |
1134188-71-8 |
| Dasatinib-d8 |
达沙替尼D8 |
1132093-70-9 |
| Rivaroxaban-d4 |
5-氯-N-[[(5S)-2-氧代-3-[4-(3-氧代-4-吗啉基)苯基-2,3,5,6-D]-5-恶唑烷基]甲基]-2-噻吩甲酰胺 |
1132681-38-9 |
| Sorafenib-d3 |
索拉非尼-D3 |
1130115-44-4 |
| Galanthamine-O-(methyl-d3)-N-(methyl-d3) |
Galanthamine-O-(methyl-d3)-N-(methyl-d3) |
1128109-00-1 |
| LINEZOLID-D3 |
利奈唑胺-D3 |
1127120-38-0 |
| Ziprasidone D8 |
齐拉西酮-D8 |
1126745-58-1 |
| SUNITINIB-D10 |
舒尼替尼-D10 |
1126721-82-1 |
| (S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
(S)-3-甲基-2-((2'-(2H-四氮唑-5-基)-4-联苯基)甲氨基)丁酸甲酯 |
1111177-24-2 |
| ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate |
缬沙坦杂质Ⅱ |
1111177-30-0 |
| 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]thio]-5-(tert-butyldimethylsilyloxy)-1H-benzimidazole |
2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]thio]-5-(tert-butyldimethylsilyloxy)-1H-benzimidazole |
1076198-62-3 |
| (±)-Venlafaxine-d6 HCl |
盐酸文拉法辛-D6 |
1062606-12-5 |
| EZM-K |
(3R,4S)-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]-4-(4-羟基苯基)氮杂环丁烷-2-酮 |
191330-56-0 |
| LOSARTAN-D4 |
氯沙坦-D4 |
1030937-27-9 |
| Lurasidone metabolite 14326 |
鲁拉西酮缓解期代谢物14326 |
186204-33-1 |
| Lurasidone Inactive Metabolite 14283 |
鲁拉西酮缓解期代谢物14283 |
186204-32-0 |
| Fexofenadine EP Impurity F |
非索芬那定EP杂质F |
185066-33-5 |
| CC-122 |
3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4H)-基)哌啶-2,6-二酮 |
1015474-32-4 |
| 2-(Carbamoyloxymethyl)-1-methyl-d3-5-nitro-imidazole |
罗硝唑D3 |
1015855-87-4 |
| Hydroxy Dimetridazole-d3 |
羟基二甲硝咪唑-D3 |
1015855-78-3 |
